• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bleeding in valvular heart disease: is von Willebrand factor the culprit?

作者信息

Bakhtari Shirin, Vincent Flavien, Susen Sophie

机构信息

Inserm, CHU Lille, Departments of Cardiology and Hemostasis, Institut Pasteur de Lille, University of Lille, U1011-EGID, Lille, France.

出版信息

Res Pract Thromb Haemost. 2024 Jul 8;8(5):102506. doi: 10.1016/j.rpth.2024.102506. eCollection 2024 Jul.

DOI:10.1016/j.rpth.2024.102506
PMID:39156182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11328092/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a70/11328092/45fda5c6f5ca/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a70/11328092/45fda5c6f5ca/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a70/11328092/45fda5c6f5ca/gr1.jpg

相似文献

1
Bleeding in valvular heart disease: is von Willebrand factor the culprit?瓣膜性心脏病中的出血：血管性血友病因子是罪魁祸首吗？
Res Pract Thromb Haemost. 2024 Jul 8;8(5):102506. doi: 10.1016/j.rpth.2024.102506. eCollection 2024 Jul.
2
[Combined Valvular Disease with Suspected Acquired von Willebrand Syndrome].合并瓣膜病伴疑似获得性血管性血友病综合征
Kyobu Geka. 2020 Mar;73(3):192-195.
3
Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor.应用重组血管性血友病因子成功治疗 1 例合并先天性血管性血友病和获得性血管性血友病综合征的小儿原位心脏移植患者的围术期管理
J Cardiothorac Vasc Anesth. 2022 Mar;36(3):724-727. doi: 10.1053/j.jvca.2021.01.038. Epub 2021 Jan 27.
4
[Acquired von Willebrand syndrome: a case series of nine patients and literature review].[获得性血管性血友病综合征：9例病例系列及文献综述]
Rev Med Interne. 2014 Mar;35(3):154-9. doi: 10.1016/j.revmed.2013.02.039. Epub 2013 Jun 7.
5
Decreased plasma ADAMTS-13 activity as a predictor of postoperative bleeding in cyanotic congenital heart disease.血浆 ADAMTS-13 活性降低可预测紫绀型先天性心脏病患者术后出血。
Clinics (Sao Paulo). 2013 Apr;68(4):531-6. doi: 10.6061/clinics/2013(04)15.
6
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial.重组血管性血友病因子和氨甲环酸治疗美国轻中度血管性血友病患者月经过多（VWDMin）：一项 3 期、开放标签、随机、交叉试验。
Lancet Haematol. 2023 Aug;10(8):e612-e623. doi: 10.1016/S2352-3026(23)00119-9. Epub 2023 Jun 26.
7
Von Willebrand factor in aortic or mitral valve stenosis and bleeding after heart valve surgery.主动脉瓣或二尖瓣狭窄及心脏瓣膜手术后出血中的血管性血友病因子。
Thromb Res. 2021 Feb;198:190-195. doi: 10.1016/j.thromres.2020.12.005. Epub 2020 Dec 16.
8
Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.抗纤维蛋白溶解疗法用于预防血友病或血管性血友病患者在接受小型口腔手术或拔牙时的口腔出血。
Cochrane Database Syst Rev. 2015 Dec 24(12):CD011385. doi: 10.1002/14651858.CD011385.pub2.
9
Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease.重度血管性血友病患者的基线血浆因子 VIII 水平及首次出血时的年龄
Haemophilia. 2016 Jul;22(4):564-9. doi: 10.1111/hae.12900. Epub 2016 Feb 4.
10
von Willebrand disease.血管性血友病。
Genet Med. 2011 May;13(5):365-76. doi: 10.1097/GIM.0b013e3182035931.

本文引用的文献

1
Mitral regurgitation is associated with similar loss of von Willebrand factor large multimers but lower frequency of anemia compared with aortic stenosis.与主动脉瓣狭窄相比，二尖瓣反流与血管性血友病因子大分子量多聚体的类似丢失相关，但贫血发生率较低。
Res Pract Thromb Haemost. 2024 May 3;8(4):102431. doi: 10.1016/j.rpth.2024.102431. eCollection 2024 May.
2
von Willebrand factor Ristocetin co-factor activity to von Willebrand factor antigen level ratio for diagnosis of acquired von Willebrand syndrome caused by aortic stenosis.血管性血友病因子瑞斯托霉素辅因子活性与血管性血友病因子抗原水平之比用于诊断主动脉瓣狭窄所致获得性血管性血友病综合征
Res Pract Thromb Haemost. 2023 Nov 30;8(1):102284. doi: 10.1016/j.rpth.2023.102284. eCollection 2024 Jan.
3
2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).2021年欧洲心脏病学会/欧洲心胸外科学会心脏瓣膜病管理指南：由欧洲心脏病学会（ESC）心脏瓣膜病管理特别工作组和欧洲心胸外科学会（EACTS）制定。
Rev Esp Cardiol (Engl Ed). 2022 Jun;75(6):524. doi: 10.1016/j.rec.2022.05.006.
4
Discrepancy in Von Willebrand Abnormalities Between Degenerative and Functional Mitral Regurgitation.退行性二尖瓣反流与功能性二尖瓣反流之间血管性血友病因子异常的差异。
Am J Cardiol. 2021 Jun 15;149:157-159. doi: 10.1016/j.amjcard.2021.03.007. Epub 2021 Mar 14.
5
Acquired von Willebrand syndrome and factor VIII in patients with moderate to severe mitral regurgitation undergoing transcatheter mitral valve repair.接受经导管二尖瓣修复术的中重度二尖瓣反流患者的获得性血管性血友病综合征和因子 VIII。
Clin Cardiol. 2021 Feb;44(2):261-266. doi: 10.1002/clc.23538. Epub 2020 Dec 29.
6
von Willebrand Factor and Management of Heart Valve Disease: JACC Review Topic of the Week.血管性血友病因子与心脏瓣膜病的管理：美国心脏病学会评论专题之周。
J Am Coll Cardiol. 2019 Mar 12;73(9):1078-1088. doi: 10.1016/j.jacc.2018.12.045.
7
Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions.作为血流生物传感器的血管性血友病因子用于监测经皮主动脉瓣介入治疗。
Circ Res. 2015 Mar 27;116(7):1193-201. doi: 10.1161/CIRCRESAHA.116.305046. Epub 2015 Feb 10.
8
Shear stress-associated acquired von Willebrand syndrome in patients with mitral regurgitation.二尖瓣反流患者与切应力相关的获得性血管性血友病综合征。
J Thromb Haemost. 2014 Dec;12(12):1966-74. doi: 10.1111/jth.12734. Epub 2014 Oct 17.
9
Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II.脉动性与使用 HeartMate II 连续流左心室辅助装置患者非手术性出血风险。
Circ Heart Fail. 2013 May;6(3):517-26. doi: 10.1161/CIRCHEARTFAILURE.112.000206. Epub 2013 Mar 11.
10
Perioperative evaluation of primary hemostasis in patients undergoing mitral valve repair.二尖瓣修复术患者围手术期原发性止血评估
HSR Proc Intensive Care Cardiovasc Anesth. 2010;2(2):119-27.